Detalhe da pesquisa
1.
Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats.
Naunyn Schmiedebergs Arch Pharmacol
; 392(4): 451-459, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30554341
2.
Pharmacological properties of ASP7657, a novel, potent, and selective prostaglandin EP4 receptor antagonist.
Naunyn Schmiedebergs Arch Pharmacol
; 391(12): 1319-1326, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076448
3.
(+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
J Med Chem
; 49(2): 716-26, 2006 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-16420057
4.
N-Arylpiperazine-1-carboxamide derivatives: a novel series of orally active nonsteroidal androgen receptor antagonists.
Chem Pharm Bull (Tokyo)
; 53(4): 402-9, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15802840